Breast Carcinoma by Gene Expression Profile

Breast Carcinoma by Gene Expression Profile — Trials · CancerIndex

Clinical trials

Registered studies

1,299 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 537
Recruiting: 296
Ph III recruiting: 38
Growth YoY: +2.8%
Industry share: 28%
Top sponsor: Fudan University
Termination share: 46%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (217)

clinicaltrialsPublishedShowing 751–800 of 1,299 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06533384	PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC	recruiting	Phase 3	310	Guangdong Provincial People's HospitalOTHER	1	Nov 4, 2024	clinicaltrials
NCT05426486	A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients	active not recruiting	Phase 2 / Phase 3	136	Caigang LiuOTHER	1	Oct 30, 2024